FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Stifel Downgrades Acumen Pharmaceuticals, Inc. (ABOS) to Hold
Tweet Send to a Friend
(Updated - October 30, 2026 9:25 AM EDT)
Stifel analyst Paul Matteis downgraded Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Paul Matteis downgraded Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
